12:00 AM
 | 
Oct 11, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zadaxin thymosin alpha 1 regulatory update

SCLN received notice of allowance for a U.S. patent covering the use...

Read the full 39 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >